Expression graph network framework for biomarker discovery.

Area of Science:

• Bioinformatics
• Computational Biology
• Genomics

Background:

• Complex diseases like cancer require identifying molecular signatures from high-dimensional gene expression data.
• Traditional methods struggle with the intricate relationships within biological data.
• Biomarker discovery is crucial for understanding disease mechanisms and advancing precision medicine.

Purpose of the Study:

• Introduce the Expression Graph Network Framework (EGNF) for enhanced biomarker discovery.
• Improve predictive identification of biomarkers by integrating graph neural networks and network-based feature engineering.
• Develop a robust and interpretable framework for complex disease research.

Main Methods:

• Constructed biologically informed networks using gene expression data and clinical attributes.
• Utilized hierarchical clustering for patient-specific molecular interaction representations.
• Applied graph learning techniques, including graph convolutional networks and graph attention networks, for gene module identification.

Main Results:

• EGNF demonstrated superior classification accuracy and interpretability compared to traditional machine learning models across three independent datasets.
• Achieved perfect separation between normal and tumor samples.
• Successfully classified disease progression and predicted treatment outcomes.

Conclusions:

• EGNF is a scalable, interpretable, and robust framework for biomarker discovery in complex diseases.
• The framework offers significant applications in precision medicine and elucidating disease mechanisms.
• EGNF advances the capability to uncover intricate molecular signatures for improved diagnostics and therapeutics.